Ostrom R S, Ehlert F J
Department of Pharmacology, College of Medicine, University of California, Irvine, USA.
J Pharmacol Exp Ther. 1997 Jan;280(1):189-99.
The purpose of this study was to characterize the role of M2 muscarinic receptors in inhibiting relaxant effects of drugs that stimulate cyclic AMP (cAMP) accumulation in the guinea pig ileum. We investigated the ability of oxotremorine-M (oxo-M) to inhibit cAMP accumulation in the presence of agonists that stimulate adenylyl cyclase in other cells and tissues. Appreciable stimulation of cAMP (> 50% over basal levels) was achieved with forskolin and maximally effective concentrations of isoproterenol, cicaprost, prostaglandin E1, prostaglandin E2 and prostaglandin I2, with the stimulation over basal levels of cAMP being 14.9-, 2.51-, 2.45-, 2.27-, 2.28- and 1.52-fold, respectively. Moderate or no cAMP stimulation was observed with dopamine, 5-hydroxytryptamine, 5-methoxytryptamine, dimaprit, vasoactive intestinal peptide, SKF-38393, 2-chloroadenosine, CGS-21680, prostaglandin D2, secretin and vasopressin. Oxo-M (1 microM) inhibited cAMP accumulation by 35% under basal conditions. Oxo-M inhibited specific agonist-stimulated cAMP levels by 20 to 70%. However, oxo-M caused little or no inhibition of specific prostaglandin I2- and cicaprost-stimulated cAMP levels (5 and 0%, respectively). In general, there was a correlation between the abilities of the various agonists to stimulate cAMP accumulation and to cause relaxation of the isolated ileum, with an exception being cicaprost. Experiments were carried out with isolated ileum to determine whether activation of M2 receptors inhibited the relaxant effects of the various agonists. In these experiments, the ileum was first treated with N-(2-chloroethyl)-4-piperidinyl diphenylacetate to selectively inactivate M3 receptors. After this treatment phase, contractile responses to oxotremorine-M were measured in the presence of histamine and a given relaxant agent. These measurements were repeated in the presence of the M2-selective antagonist AF-DX 116. Analysis of the data showed that part of the contractile response to oxotremorine-M could be attributed to an M2-mediated inhibition of the relaxation. This M2 component of the contractile response was greatest when forskolin or isoproterenol was used as the relaxant agent. In contrast, little or no M2 response was measured in the presence of dopamine and cicaprost.
本研究的目的是确定M2毒蕈碱受体在抑制刺激豚鼠回肠中环磷酸腺苷(cAMP)积累的药物的舒张作用中所起的作用。我们研究了氧化震颤素-M(oxo-M)在存在刺激其他细胞和组织中腺苷酸环化酶的激动剂的情况下抑制cAMP积累的能力。用福斯高林以及异丙肾上腺素、西卡前列素、前列腺素E1、前列腺素E2和前列腺素I2的最大有效浓度可实现对cAMP的显著刺激(比基础水平高>50%),cAMP比基础水平的刺激倍数分别为14.9、2.51、2.45、2.27、2.28和1.52倍。用多巴胺、5-羟色胺、5-甲氧基色胺、二甲双胍、血管活性肠肽、SKF-38393、2-氯腺苷、CGS-21680、前列腺素D2、促胰液素和血管加压素时,观察到对cAMP的刺激作用中等或无刺激作用。在基础条件下,1μM的oxo-M可使cAMP积累减少35%。oxo-M可使特定激动剂刺激的cAMP水平降低20%至70%。然而,oxo-M对特定的前列腺素I2和西卡前列素刺激的cAMP水平几乎没有抑制作用(分别为5%和0%)。一般来说,各种激动剂刺激cAMP积累的能力与引起离体回肠舒张的能力之间存在相关性,但西卡前列素除外。用离体回肠进行实验以确定M2受体的激活是否抑制各种激动剂的舒张作用。在这些实验中,回肠首先用N-(2-氯乙基)-4-哌啶基二苯基乙酸酯处理以选择性地使M3受体失活。在这个处理阶段之后,在组胺和给定的舒张剂存在的情况下测量对氧化震颤素-M的收缩反应。在M2选择性拮抗剂AF-DX 116存在的情况下重复这些测量。数据分析表明,对氧化震颤素-M的部分收缩反应可归因于M2介导的舒张抑制。当使用福斯高林或异丙肾上腺素作为舒张剂时,收缩反应的这个M2成分最大。相比之下,在多巴胺和西卡前列素存在的情况下,几乎没有测量到M2反应。